New Clinical Trial Regulations in the UK

New draft proposals on clinical trial regulations in the UK have been developed collaboratively by the NHS Health Research Authority and the MHRA (Medicines and Healthcare products Regulatory Agency).

New UK Clinical Trial Amendments Regarding Regulatory Regulations

On Thursday, 12th December, the Statutory Instrument (SI) was laid before Parliament. These amendments, once approved by Parliament, will modernize the regulatory framework and represent the most significant reform of the regulations in 20 years.

Key takeaways from these amendments include:

• • The new legislation aims to streamline and make clinical trial regulations more flexible, reduce administrative burdens, and ensure participant protection. It introduces Combined Review into law and establishes clear standards for conducting trials in the UK.
  • The regulations mandate registering clinical trials in a WHO-recognized public register, publishing results within 12 months, and ensuring timely, understandable communication of findings to participants.
  • The updated regulations permit simplified consent processes for ‘lower risk’ trials involving already approved medicines, with ongoing consultations for feedback on this approach.
  • The new provisions replace restrictive 2004 requirements for Research Ethics Committees with more flexible measures aligned with international standards, enhancing their ability to meet demand and respond to changing circumstances.
  • The government will support good clinical trial practices through guidance rather than legislative changes, ensuring diverse representation and public involvement based on feedback from the 2022 consultation.
  • A 2023 survey revealed strong public support for including diverse participants in research. This has led to new guidance and draft questions for researchers to develop Inclusion and Diversity Plans, created with input from the public and research community.
  • High-quality clinical trials not only improve NHS care but also contribute over £7 billion annually to the UK economy, support 65,000 jobs, and are strengthened by a new £100 million investment in 20 clinical research hubs.

Questions? Contact us.

Learn how MedEnvoy can assist you:

• • UK Responsible Person
  • RA Consulting
  • QA Consulting